105823-04-9 Usage
General Description
1',2'-dimethylheptyl-1-deoxy-delta(8)-tetrahydrocannabinol, also known as DMH-D8-THC, is a synthetic cannabinoid compound that acts as a potent agonist at the cannabinoid receptors, producing similar effects to natural THC, but with a longer duration of action. It is derived from tetrahydrocannabinol (THC) and is known for its high potency and psychoactive effects. DMH-D8-THC is often used in scientific research to study the effects of cannabinoids on the body and to develop potential medical applications. 1',2'-dimethylheptyl-1-deoxy-delta(8)-tetrahydrocannabinol is considered to be significantly more potent than natural THC and may have a variety of potential therapeutic uses, though further research is needed to fully understand its effects and potential risks.
Check Digit Verification of cas no
The CAS Registry Mumber 105823-04-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,5,8,2 and 3 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 105823-04:
(8*1)+(7*0)+(6*5)+(5*8)+(4*2)+(3*3)+(2*0)+(1*4)=99
99 % 10 = 9
So 105823-04-9 is a valid CAS Registry Number.
105823-04-9Relevant articles and documents
Novel cannabinol probes for CB1 and CB2 cannabinoid receptors
Mahadevan,Siegel,Martin,Abood,Beletskaya,Razdan
, p. 3778 - 3785 (2000)
The observation that the phenolic hydroxyl of THCs was important for binding to the CB1 receptor but not as critical for binding to the CB2 receptor prompted us to extend this finding to the cannabinol (CBN) series. To study the SAR of CBN analogues, CBN
CANNABINOIDS AND USES THEREOF
-
Page/Page column 92-93, (2019/12/25)
The invention relates to cannabinoid compounds, pharmaceutical compositions including one or more cannabinoid compounds, and the use of pharmaceutical compositions including one or more cannabinoid compounds for the treatment of a disease or condition (e.
